The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain

Molecular and Cellular Biology

Volumn 17, Issue 1, 1997, Pages 154-162

  Brehm, Alexander ^a   Ohbo, Kazuyuki ^a   Schöler, Hans ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHOPEPTIDE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO DEVELOPMENT; HELA CELL; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSACTIVATION;

ANIMALIA; MURINAE;

EID: 0031014396     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.1.154     Document Type: Article

References (61)

1. Annweiler, A., I. M. Muller, and T. Wirth. 1992. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol. Cell. Biol. 12:3107-3116.
2. Annweiler, A., S. Zwilling, and T. Wirth. 1994. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res. 22:4250-4258.
3. Baichwal, V. R., A. Park, and R. Tjian. 1992. The cell-type-specific activator region of c-Jun juxtaposes constitutive and negatively regulated domains. Genes Dev. 6:1493-1502.
4. Baichwal, V. R., A. Park, and R. Tjian. 1991. v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor. Nature 352:165-168.
5. Baichwal, V. R., and R. Tjian. 1990. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v-and c-Jun. Cell 63:815-825.
6. Bodner, M., J. L. Castrillo, L. E. Theill, T. Deerinck, M. Ellisman, and M. Karin. 1988. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55:505-518.
7. Cleary, M. A., S. Stern, M. Tanaka, and W. Herr. 1993. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct1 and VP16 corecruitment. Genes Dev. 7:72-83.
8. Collarini, E. J., R. Kuhn, C. J. Marshall, E. S. Monuki, G. Lemke, and W. D. Richardson. 1992. Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro. Development 116: 193-200.
9. Friedl, E. M., and P. Matthias. 1995. Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a. Eur. J. Biochem. 234:308-316.
10. Gerber, H. P., K. Seipel, O. Georgiev, M. Hofferer, M. Hug, S. Rusconi, and W. Schaffner. 1994. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808-811.
11. Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C. M. Hovens. 1195. A B-cell coactivator of octamer-binding transcription factors. Nature 373:360-362.
12. Harlow E., and D. Lane. 1988. Antibodies-a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
13. Herr, W., and M. A. Cleary. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1679-1693.
14. 13a.Hess, H. Unpublished observation.
15. Imagawa, M., A. Miyamoto, M. Shirakawa, H. Hamada, and M. Muramatsu. 1991. Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3. Nucleic Acids Res. 19:4503-4508.
16. lngraham, H. A., R. P. Chen, H. J. Mangalam, H. P. Elsholtz, S. E. Flynn, C. R. Lin, D. M. Simmons, L. Swanson, and M. G. Rosenfeld. 1988. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519-529.
17. Kapiloff, M. S., Y. Farkash, M. Wegner, and M. G. Rosenfeld. 1991. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253:786-789.
18. Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21-32.
19. Leger, H., E. Sock, K. Renner, F. Grummt, and M. Wegner. 1995. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-1/Y. Mol. Cell. Biol. 15:3738-3747.
20. Li, X. Y., and M. R. Green. 1996. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10:517-527.
21. Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature 338:39-44.
22. Livingstone, C., G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1785-1797.
23. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
24. Luo, Y., H. Fujii, T. Gerster, and R. G. Roeder. 1992 A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71:231-241.
25. Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115-4124.
26. Matthias, P., M. M. Muller, E. Schreiber, S. Rusconi, and W. Schaffner. 1989. Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res. 17:6418.
27. McKnight, S. L., and R. Kingsbury. 1982. Transcriptional control signals of a eukaryotic protein-coding gene. Science 217:316-324.
28. Minucci, S., V. Botquin, I. Y. Young, A. Dey, I. Sylvester, D. J. Zand, K. Ohbo, K. Ozato, and H. Schöler. 1996. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 15:888-899.
29. Monuki, E. S., R. Kuhn, and G. Lemke. 1993. Cell-specific action and mutable structure of a transcription factor effector domain. Proc. Natl. Acad. Sci. USA 90:9978-9982.
30. Muller, I. M., W. Schaffner, and P. Matthias. 1990. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 9:1625-1634.
31. Palmieri, S. L., W. Peter, H. Hess, and H. R. Schöler. 1994. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 166:259-267.
32. Papavassiliou, A. G., M. Treier, C. Chavrier, and D. Bohmann. 1992. Targeted degradation of c-Fos. but not v-Fos, by a phosphorylation-dependent signal on c-Jun. Science 258:1941-1944.
33. Pfisterer, P., A. Annweiler, C. Ullmer, L. M. Corcoran, and T. Wirth. 1994. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 13:1655-1663.
34. Rosner, M. H., M. A. Vigano, K. Ozato, P. M. Timmons, F. Poirier, P. W. Rigby, and L. M. Staudt. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
35. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
36. Scheidereit, C., J. A. Cromlish, T. Gerster, K. Kawakami, C. G. Balmaceda, R. A. Currie, and R. G. Roeder. 1988. A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature 336:551-557.
37. Schiller, P., J. Amin, J. Ananthan, M. E. Brown, W. A. Scott, and R. Voellmy. 1988. Cis-acting elements involved in the regulated expression of a human HSP70 gene. J. Mol. Biol. 203:97-105.
38. Schöler, H. R. 1991. Octamania: the POU factors in murine development. Trends Genet. 7:323-329.
39. Schöler, H. R., T. Ciesiolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66:291-304.
40. Schöler, H. R., G. R. Dressier, R. Balling, H. Rohdewohid, and P. Gruss. 1990. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9:2185-2195.
41. Schöler, H. R., A. K. Hatzopoulos, R. Balling, N. Suzuki, and P. Gruss. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8:2543-2550.
42. Schöler, H. R., S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss. 1990. New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.
43. Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote ("enhancer") and proximal ("promoter") positions. EMBO J. 11:4961-4968.
44. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497-506.
45. Sturm, R. A., and W. Herr. 1988. The POU domain is a bipartite DNA-binding structure. Nature 336:601-604.
46. Sylvester, I., and H. R. Schöler. 1994. Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res. 22:901-911.
47. Tanaka, M., W. M. Clouston, and W. Herr. 1994. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription. Mol. Cell. Biol. 14:6046-6055.
48. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386.
49. Tanaka, M., and W. Herr. 1994. Reconstitution of transcriptional activation domains by reiteration of short peptide segments reveals the modular organization of a glutamine-rich activation domain. Mol. Cell. Biol. 14:6056-6067.
50. Tanaka, M., J. S. Lai, and W. Herr. 1992. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68:755-767.
51. Treacy, M. N., L. I. Neilson, E. E. Turner, X. He, and M. G. Rosenfeld. 1992. Twin of I-POU: a two amino acid difference in the I-POU homeodomain distinguishes an activator from an inhibitor of transcription. Cell 68:491-505.
52. Triezenberg, S. J. 1995. Structure and function of transcriptional activation domains. Curr. Opin. Genet. Dev. 5:190-196.
53. Verrijzer, C. P., and P. van der Vliet. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173:1-21.
54. Vigano, M. A., and L. M. Staudt. 1996. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Res. 24:2112-2118.
55. Wegner, M., D. W. Drolet, and M. G. Rosenfeld. 1993. Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90:4743-4747.
56. Wirth, T., L. Staudt, and D. Baltimore. 1987. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature 329:174-178.
57. Yang, J., I. M. Muller, K. Seipel, L. Janson, G. Westin, W. Schaffner, and U. Pettersson. 1991. Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes. EMBO J. 10:2291-2296.
58. Yeom, I. Y., G. Fuhrmann, C. E. Ovitt, A. Brehm, K. Ohbo, M. Gross, K. Hübner, and H. Schüler. 1996. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122:881-894.
59. Yeom, Y. I., H. S. Ha, R. Balling, H. R. Schöler, and K. Artzt. 1991. Structure, expression and chromosomal location of the Oct-4 gene. Mech. Dev. 35:171-179.
60. Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635-2645.
61. Zwilling, S., H. Konig, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14:1198-1208.